WeVote
Log In

Bill

Bill

SB 1752

mescaline; possession; sale; commercial use

57th Legislature - Second Regular Session Introduced by Flavio Bravo and 4 co-sponsors

Arizona bill would decriminalize mescaline possession and establish regulated commercial use framework, creating state-federal legal tension while advancing psychedelic policy reform.

House First Reading.
0
WeVote Research Nonpartisan
Bill Summary · SB 1752

Legislative bill overview

SB 1752 would decriminalize possession and allow regulated commercial use of mescaline, a naturally occurring psychedelic compound found in certain cacti and plants. The bill appears to establish a legal framework for personal possession limits and potentially licensed commercial cultivation or sales of mescaline-containing products.

Why is this important

Mescaline remains a Schedule I controlled substance under federal law, making this a significant shift in state drug policy that could conflict with federal regulations. This follows growing interest in psychedelic-assisted therapies and reflects broader movement toward drug policy reform, though federal enforcement remains a substantial legal and practical concern.

Potential points of contention

  • Federal-state legal conflict: Schedule I status means federal law enforcement could still prosecute despite state legalization, creating legal ambiguity for businesses and consumers
  • Public health concerns: Questions about appropriate dosing standards, quality control, adverse effects monitoring, and potential for abuse without established medical oversight
  • Implementation challenges: Defining which plant species qualify, establishing possession thresholds, designing licensing systems, and addressing how state law interacts with federal jurisdiction over interstate commerce
  • Medical legitimacy debate: Mescaline research for therapeutic use is ongoing but limited; opponents may question rushing legalization before clinical evidence solidifies

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.